Full Press Release Details
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission.
BIIB
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission
Key Takeaway: Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission